Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |